PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Outcomes-Based Contracting: The Next Step to Better Patient Care

On a Double Mission: Chris Round, Merck KGaA, Darmstadt, Germany

PIE (PRE-APPROVAL INFORMATION EXCHANGE) IS GOOD FOR YOU

Top Story
Pharm Exec's 15th Annual Press Audit: Opioid Crisis Dominates the News
Our annual audit of press coverage of the pharmaceutical industry shows that the opioid crisis dominated the news for the second consecutive year
… /Read more/
Regulatory
FDA Challenges USP Standards for Biologics
A provision in a Senate health reform bill has reignited debate over the whether biological products should have to meet product quality standards established by the U.S. Pharmacopeia
… /Read more/
ADVERTISEMENT

Special Feature
Pharm Exec's Top 50 Companies 2019
Our 19th annual listing reveals some interesting maneuvering of ranks, as companies focus on diversification, big-brand expansions, and positioning a new wave of products to compete in an advancing but complex future treatment market
… /Read more/
 
Technology
Digital Therapeutics Can Break Down Barriers to Innovation to Benefit Patients
Pharma companies are increasingly turning to tech enabled behavioral-based interventions to help improve patient outcomes through their diagnosis, treatment, and coordination of care, writes Leo Grimaldi
… /Read More/
 
Audio
The Pharm Exec Podcast: The Future of the Life Sciences Executive
Cameron Turtle, Chief Business Officer of Eidos Therapeutics, Robin Toft, Founder and CEO of The Toft Group Executive Search, and Sabrina Johnson, President and CEO, Daré Bioscience, join the Pharm Exec editors to talk about the future of the life sciences executive
… /Click here to listen/
Calendar
/ July 8–9: Leadership for Drug Development Teams /
Boston, MA
/ August 8–9: Direct-to-Patient Clinical Trials /
Philadelphia, PA
/ September 10–11: 5th Annual Bio/Pharmaceutical Product Launch Summit /
Cambridge, MA
/ September 12– 13: 5th Annual Compliance Congress for Specialty Products /
Cambridge, MA
/ September 18–19: 5th Edition Drug Pricing Transparency Congress /
Philadelphia, PA.
/ October 8–9: Life Sciences West Coast Compliance Congress /
San Francisco, CA,
/ November 13–14: 6th Annual Global Compliance Congress /
London, UK
/ December 11: eyeforpharma Awards 2019 /
Philadelphia, PA.

Industry update
//BioCryst Pharmaceuticals (Research Triangle Park, NC) announced the appointment of Megan Sniecinski as Chief Business Officer. // Agios Pharmaceuticals (Cambridge, MA) appointed Orlando Oliveira to the role of Senior Vice President and General Manager, International. // Abeona Therapeutics (New York, NY and Cleveland, OH) appointed Victor Paulus, Ph.D. as Senior Vice President, Regulatory Affairs. // Recursion Pharmaceuticals (Salt Lake City, UT) named Dr. Sharath Hegde as Chief Scientific Officer. // Pacira BioSciences (Parsippany, NJ) announced the appointment of Max Reinhardt as the company's president. // Celldex Therapeutics (Hampton, NJ) announced the appointment of Diane C. Young, M.D., as Senior Vice President, Chief Medical Officer, effective July 8.//
advertise with us / print subscribe / digital subscribe / visit pharmexec.com